Company Filing History:
Years Active: 2023-2025
Title: Innovations by Alexander Thorman
Introduction
Alexander Thorman is an accomplished inventor based in Cincinnati, OH. He has made significant contributions to the field of medical research, particularly in the area of immune response modulation. With a total of 3 patents to his name, Thorman's work is focused on developing therapeutic compounds that can inhibit specific proteins involved in inflammation.
Latest Patents
Thorman's latest patents include groundbreaking research on compounds useful for inhibiting BFL1 and their application in therapy. The first patent discloses compounds of Formula I and their use in methods of modulating an immune response by inhibiting BFL1. This research is particularly relevant for treating and preventing diseases characterized by inflammation, especially those induced by neutrophils. The second patent outlines methods of attenuating an immune response through the inhibition of BFL1, further emphasizing the potential for these compounds in therapeutic applications.
Career Highlights
Thorman is currently affiliated with the Children's Hospital Medical Center, where he continues to advance his research. His work is instrumental in developing new strategies for managing inflammatory diseases, showcasing his commitment to improving patient outcomes through innovative solutions.
Collaborations
Some of Thorman's notable coworkers include David A. Hildeman and Suhas G. Kallapur. Their collaborative efforts contribute to the ongoing research and development of new therapeutic approaches.
Conclusion
Alexander Thorman's innovative work in the field of immune response modulation highlights his dedication to advancing medical research. His patents reflect a commitment to finding effective treatments for inflammatory diseases, making a significant impact in the healthcare sector.